Jennison Associates’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-39,978
Closed -$650K 581
2023
Q4
$650K Sell
39,978
-364,461
-90% -$4.65M ﹤0.01% 544
2023
Q3
$5.59M Sell
404,439
-301,681
-43% -$4.75M ﹤0.01% 409
2023
Q2
$15.6M Sell
706,120
-219,261
-24% -$4.62M 0.01% 343
2023
Q1
$20.1M Sell
925,381
-67,858
-7% -$1.53M 0.02% 328
2022
Q4
$18.1M Buy
993,239
+389,812
+65% +$8.05M 0.02% 333
2022
Q3
$13.7M Buy
603,427
+147,324
+32% +$3.15M 0.01% 365
2022
Q2
$6.3M Buy
456,103
+33,761
+8% +$495K 0.01% 421
2022
Q1
$9.6M Sell
422,342
-415,907
-50% -$10.9M 0.01% 425
2021
Q4
$31.2M Buy
838,249
+543,914
+185% +$23.3M 0.02% 289
2021
Q3
$12.5M Sell
294,335
-10,023
-3% -$483K 0.01% 428
2021
Q2
$13.5M Sell
304,358
-5,900
-2% -$208K 0.01% 426
2021
Q1
$11.2M Sell
310,258
-139,316
-31% -$5.51M 0.01% 413
2020
Q4
$17.9M Buy
+449,574
New +$15.3M 0.01% 348

Other funds holding BLFS

Jennison Associates's BLFS Position: Q1 2024 in Review

Jennison Associates sold out of BioLife Solutions (BLFS) in Q1 2024, closing a stake of 39,978 shares — an estimated $650K sold.

Jennison Associates first reported a position in BLFS in Q4 2020 and held it in 13 quarters. The position peaked at $31.2M in Q4 2021. 149 funds tracked by Wall St. Rank hold BLFS as of Q1 2024.

  • Jennison Associates reported no remaining BioLife Solutions position as of Q1 2024 after selling out during the quarter.
  • Jennison Associates sold 39,978 BioLife Solutions shares in Q1 2024, an estimated $650K.
  • Jennison Associates first reported a position in BioLife Solutions in Q4 2020 and held it in 13 quarters.
  • Jennison Associates's BioLife Solutions position peaked at $31.2M in Q4 2021.
  • 149 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2024.

Based on Jennison Associates's 13F filing for Q1 2024, filed 2 May 2024.